Dr. Mohammed Ibrahim, MD

Dr. Mohammed Ibrahim, MD

Hematology & Oncology  ·  
Male  ·  
Age 40
(1)
Save
Dr. Mohammed Ibrahim, MD is a hematology & oncology specialist in Royal Oak, MI and has been practicing for 19 years. He graduated from Wayne State University School Of Medicine in 1999 and specializes in hematology & oncology.

3577 W 13 Mile Rd Ste 202

Royal Oak, MI 48073

Contact Information

(248) 551-0268

Insurance Accepted

  • Blue Cross Blue Shield
  • Cigna
  • HAP Insurance
  • MultiPlan
  • Priority Health

*Please verify this information when scheduling an appointment.

Background Check

Healthgrades does not collect malpractice information for Michigan
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Ibrahim's experience treating your condition or procedure

Dr. Ibrahim's Top Procedures and Conditions

Treatment Frequency
Blood Disorders
high
high

Treatment Frequency

Dr. Ibrahim treats Blood Disorders more than 80% of his peers

Dr. Ibrahim treats this condition more than 80% of his peers

Anemia
normal
normal

Treatment Frequency

Dr. Ibrahim treats Anemia more than 74% of his peers

Dr. Ibrahim treats this condition more than 74% of his peers

Rating Includes other areas of care:

  • Acquired Aplastic Anemia
  • Anemia of Pregnancy
  • Aplastic Anemia
  • Atypical Hemolytic Uremic Syndrome
  • Autoimmune Hemolytic Anemia (AIHA)
  • Chronic Anemia
  • Cold Autoimmune Hemolytic Anemia
  • Diamond-Blackfan Anemia
  • D-Negative Hemolytic Uremic Syndrome (D - HUS)
  • D-Negative Hemolytic Uremic Syndrome, Pregnancy Related
  • D-Positive Hemolytic Uremic Syndrome (D + HUS)
  • Hemolytic Anemia, Acquired Autoimmune
  • Hemolytic Uremic Syndrome
  • Hereditary Spherocytosis
  • Iron Deficiency Anemia
  • Megaloblastic Anemia
  • Microcytic Hypochromic Anemia
  • Myelpathic Anemia
  • Neonatal Anemia
  • Nutritional Anemia
  • Nutritional Sideroblastic Anemia
  • Pernicious Anemia
  • Refractory Anemia With Excess Blasts
  • Refractory Anemia With Excess Blasts-1
  • Refractory Anemia With Excess Blasts-2
  • Secondary Cold Autoimmune Hemolytic Anemia
  • Sideroblastic Anemia
  • Sideroblastic Anemia With Spinocerebellar Ataxia
  • Sideroblastic Anemia, Pyridoxine-Responsive, Autosomal Recessive
  • Warm Autoimmune Hemolytic Anemia
Cancer
normal
normal

Treatment Frequency

Dr. Ibrahim treats Cancer more than 72% of his peers

Dr. Ibrahim treats this condition more than 72% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer

Dr. Ibrahim's conditions and procedures:

All Lymphoma
Anemia
Autoimmune Diseases
Bleeding Disorders
Blood Disorders
Bone Disorders
Bone Marrow Biopsy
Cancer
Chronic Myeloid Leukemia (CML)
Deep Vein Thrombosis (DVT)
Leukocytosis
Myeloproliferative Disorders
Non-Hodgkin's Lymphoma
Pancytopenia
Reticulosarcoma
Thrombosis
Vascular Disease
Venous Embolism and Thrombosis

About Me

Biography

Dr. Mohammed Ibrahim, MD is a hematology & oncology specialist in Royal Oak, MI and has been practicing for 19 years. He graduated from Wayne State University School Of Medicine in 1999 and specializes in hematology & oncology.

Specialties

  • Hematology & Oncology

Board Certifications

  • Hematology
  • Internal Medicine
  • Medical Oncology

Education

  • 1999
    Wayne State University School Of Medicine
    Medical School
    1999

Awards

Dr. Ibrahim's Reviews

Likelihood to recommend Dr. Ibrahim

5.0

Based on 1 reviews

5 Stars
100%
(1)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
0%
(0)

Leave a review

How likely are you to recommend
Dr. Ibrahim?
(Select your rating)
What People Say About Dr. Mohammed Ibrahim, MD
Reply
Dr. Ibrahim is a staff doctor in the hospital and sees me when I am an inpatient. He is part of a team of oncologists. He is always very friendly and very respectful and he seems very knowledgeable and caring.
Was this helpful?
thumbs up icon option1
thumbs down icon option
×Post a ResponseAre you Dr. Mohammed Ibrahim, MD?

Leave a review

How was your experience with Dr. Ibrahim?

Locations

Insurance accepted

Accepted insurance can change. Please double-check when making an appointment.

Blue Cross Blue Shield
Blue Card PPO
Cigna
Cigna HMO
Cigna PPO
Open Access Plus
HAP Insurance
Preferred PPO
MultiPlan
MultiPlan PPO
PHCS Network PPO
Priority Health
Priority PPO

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Ibrahim treats patients.

Learn more